Drug & medication recalls Moderate risk

Zydus Pharmaceuticals USA Inc recalls ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-…

Recall date
March 6, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0605-2017
FDA classification
Class II
Brand / firm
Zydus Pharmaceuticals USA Inc
Sold / distributed
Nationwide in the USA and Puerto Rico.

Why it was recalled

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Get recall alerts

Free email alert whenever Zydus Pharmaceuticals USA Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Zydus Pharmaceuticals USA Inc